Abbott Laboratories (ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	187,950	217,859	196,184	191,088	191,427	241,365
Market Cap Growth	-16.09%	11.05%	2.67%	-0.18%	-20.69%	28.66%
Enterprise Value	215,090	223,411	203,674	199,953	198,309	250,286
Last Close Price	108.52	122.25	108.31	103.34	101.06	127.41

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	40.35	33.52	14.64	33.52	27.72	34.28
Forward PE	18.60	22.63	22.39	24.22	26.64	30.05
PS Ratio	3.90	4.92	4.68	4.76	4.39	5.60
PB Ratio	3.68	4.13	4.10	4.92	5.19	6.70
P/TBV Ratio	-	9.65	10.96	31.28	55.76	-
P/FCF Ratio	27.82	29.46	30.89	37.77	24.53	27.91
P/OCF Ratio	21.23	22.77	22.92	26.32	19.98	22.92
PEG Ratio	1.98	2.35	2.61	2.85	5.16	2.38

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	4.46	5.04	4.86	4.99	4.54	5.81
EV/EBITDA Ratio	18.77	18.57	19.01	19.11	16.02	19.64
EV/EBIT Ratio	28.50	25.05	27.17	27.69	21.76	27.19
EV/FCF Ratio	31.83	30.21	32.07	39.52	25.41	28.94

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.61	0.27	0.32	0.41	0.49	0.53
Debt / EBITDA Ratio	2.65	1.14	1.38	1.48	1.41	1.47
Debt / FCF Ratio	4.65	1.91	2.41	3.16	2.30	2.23
Net Debt / Equity Ratio	0.53	0.10	0.15	0.22	0.21	0.25
Net Debt / EBITDA Ratio	2.37	0.43	0.69	0.83	0.63	0.71
Net Debt / FCF Ratio	4.02	0.70	1.16	1.72	1.00	1.04
Asset Turnover	0.50	0.53	0.54	0.54	0.58	0.58
Inventory Turnover	2.94	3.03	2.92	2.81	3.37	3.56
Quick Ratio	0.83	1.02	1.05	1.00	1.06	1.28
Current Ratio	1.46	1.58	1.67	1.64	1.63	1.85
Return on Equity (ROE)	9.14%	12.96%	30.91%	15.11%	19.01%	20.49%
Return on Assets (ROA)	4.90%	6.63%	6.06%	6.11%	7.61%	7.79%
Return on Invested Capital (ROIC)	6.86%	12.14%	14.59%	13.45%	16.96%	17.46%
Return on Capital Employed (ROCE)	8.20%	12.70%	11.10%	12.20%	15.50%	14.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.48%	3.00%	6.83%	3.00%	3.62%	2.93%
FCF Yield	3.60%	3.39%	3.24%	2.65%	4.08%	3.58%
Dividend Yield	2.32%	1.91%	1.98%	1.89%	1.74%	1.33%
Payout Ratio	93.70%	63.09%	28.62%	62.13%	47.73%	45.28%
Buyback Yield / Dilution	0.27%	-0.06%	0.06%	0.85%	1.40%	-0.17%
Total Shareholder Return	2.59%	1.86%	2.03%	2.74%	3.14%	1.16%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error